News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Amazon is Considering a $9 Billion Deal to Acquire Satellite Communications Company Globalstar. Here's Why Amazon, Apple, and Tesla Investors Should Pay Attention.2Exxon’s Guyana-Permian Engine Fuels 21% Earnings Growth—Is the 24 P/E Already Discounting a Squeeze?3Bitcoin’s Movement Compared to Oil’s Rally: Evaluating a Risk-Off Scenario
Ross Stores Stock Rises 0.19% as $720M Trading Volume Pushes Shares to 197th Most Active in the Market
101 finance·2026/03/09 23:25
Union Pacific's 0.20% Drop and 31.14% Volume Decline to $0.72 Billion See Stock Rank 194th Amid Merger Jitters
101 finance·2026/03/09 23:25
Comfort Systems USA Jumps 7.3% on $790M Volume, Ranking 176th, as Unexpected Rally Leaves Analysts Baffled
101 finance·2026/03/09 23:21
EQT Energy Gains 0.44% on $750M Volume Spike as UK Water Acquisition Pushes Stock to 186th Rank
101 finance·2026/03/09 23:21
Credo Tech Surges 5.6% on Strong Q3 Results Despite After-Hours Dip and 168th Volume Rank
101 finance·2026/03/09 23:19
Charles Schwab Stock Falls 0.89% as Trading Volume Ranks 175th Amid Mixed Analyst Outlook and Insider Sales
101 finance·2026/03/09 23:18
NXP Gains 1.74% Amid Shifting Earnings Trends, Trading Volume Hits $750M, Ranking 185th
101 finance·2026/03/09 23:18
Shell (SHEL) Surpasses Broader Market Performance: Key Insights
101 finance·2026/03/09 23:18
Flash
21:46
Regenerative medicine giant Organogenesis Holdings Inc (ORGO) recently announced the successful completion of a key meeting with the U.S. Food and Drug Administration (FDA).The two parties reached a consensus on the clinical development pathway of Renu® regenerative cell technology for the treatment of knee osteoarthritis pain. The company clearly stated that it will accelerate the regulatory submission process based on the meeting's guidance and plans to officially submit a Biologics License Application (BLA). This innovative therapy aims to target and repair knee cartilage tissue through a cell regeneration mechanism, providing a new non-surgical intervention option for hundreds of millions of osteoarthritis patients worldwide. This milestone event marks a significant breakthrough in the commercialization process of the Renu® product. Industry analysts pointed out that if approved for market launch, this product could reshape the market landscape of the orthopedic pain treatment sector. Influenced by this positive news, the company’s stock price showed an upward trend in after-hours trading.
21:42
(PAC) Fairshake: Holds $193 million in campaign funds ahead of the November 2026 midterm electionsJinse Finance reported that on April 7, the cryptocurrency-backed political action committee (PAC) Fairshake stated it had spent over $130 million on media buying for the 2024 election. The committee said in January that it has $193 million in campaign funds available through the November 2026 midterm elections. The organization is not the only group supporting cryptocurrency nationwide. Fellowship PAC claims to have raised "over $100 million" from undisclosed backers closely linked with the cryptocurrency industry, and on Wednesday, announced the appointment of Tether executive Jesse Spiro as chairperson.
21:24
Bitcoin's 30-day average transaction fee drops to the lowest level since 2011The 30-day average transaction fee for Bitcoin has dropped to 2.5 BTC per day, the lowest level since 2011, indicating weak on-chain demand. (Cointelegraph)
News